Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 2:37 AM
Recent mergers and acquisitions in the Biotechnology M&A category.
| This Slide: #83 of 83 |
Slide #83. Charles River Laboratories International, Inc. — Accugenix, Inc.
Acquirer:
Charles River Laboratories International, Inc. (NYSE:CRL)
Acquiree:
Accugenix, Inc.
Details:
Charles River Laboratories International, Inc. announced that it has acquired Accugenix, Inc. for approximately $17 million in cash.
Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
CRL SEC Filing Email Alerts Service
Open the CRL Page at The Online Investor »
|
|||||||||||||||||||||
Open the CRL Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.79 out of 4) 71st percentile
(ranked higher than approx. 71% of all stocks covered)
Analysts' Target Price: CRL Stock Forecast Based on Zacks ABR data; powered by Xignite |
